Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China
ChiTwiMC
1 other identifier
observational
2,000
1 country
11
Brief Summary
Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China (ChiTwiMC) is supported by National Key Research and Development Program of China - Reproductive Health and Women's and Children's Health Protection Project. This project is funded by the Ministry of Science and Technology of China under grant number 2023YFC2705900. The ChiTwiMC cohort is led by Professor Wei Yuan from the Department of Gynecology and Obstetrics at Peking University Third Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Typical duration for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 17, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
May 16, 2024
January 1, 2024
2.8 years
March 17, 2024
May 9, 2024
Conditions
Outcome Measures
Primary Outcomes (9)
Rate of preterm delivery
Preterm delivery is defined as delivery between 28 and 37 gestational weeks.
From inclusion to delivery
Rate of preeclampsia
Preeclampsia is defined as the condition occurring in pregnant women after 20 weeks of gestation, characterized by systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, accompanied by any of the following: a urinary protein quantification ≥0.3 g/24 h, or a urine protein/creatinine ratio ≥0.3, or random urine protein ≥ (+) (as a method of examination when protein quantification is not feasible). In the absence of proteinuria, the condition may still be diagnosed if there is involvement of any organ or system, including but not limited to critical organs such as the heart, lungs, liver, kidneys, or abnormalities in the hematological, digestive, or neurological systems, as well as complications affecting the placenta-fetus.
From inclusion to delivery
Rate of twin-to-twin transfusion syndrome (TTTS)
TTTS is diagnosed in monochorionic diamniotic twin pregnancies when there is a discordance in amniotic fluid volumes, with one fetus exhibiting polyhydramnios and the other oligohydramnios. Specifically, before 20 weeks of gestation, the condition is diagnosed if one fetus (the recipient) has a deepest vertical pocket (DVP) of amniotic fluid ≥8cm, while the other fetus (the donor) has a DVP ≤2cm; after 20 weeks of gestation, the diagnosis is made if one fetus (the recipient) has a DVP ≥10cm, while the other fetus (the donor) has a DVP ≤2cm.
From inclusion to delivery
Rate of selective fetal growth restriction (sFGR)
sFGR is diagnosed in monochorionic diamniotic twin pregnancies when one fetus has an estimated fetal weight below the 10th percentile for its gestational age, and there is a discrepancy of ≥25% in the estimated fetal weights between the two fetuses.
From inclusion to delivery
Rate of fetal brain injury
Fetal brain injury is an abnormality in the structural and functional integrity of the cerebrum, cerebellum, or brainstem during the gestational period, caused by various factors such as hypoxic-ischemic events, infections, hemorrhage, congenital malformations, and genetic metabolic disorders.
From inclusion to delivery
Rate of neonatal brain injury
Brain injury refers to damage to the central nervous system resulting from various risk factors during pregnancy, childbirth, and the neonatal period. Clinically, it manifests as central motor disorders, cognitive impairments, language disorders, visual and auditory impairments, as well as difficulties in social interaction and psychological and behavioral disorders. It needs pregnant history or birth history, (such as one of twin intrauterine fetal death, Intrauterine distress), manifestation, and ultrasound, CT, MRI, electroencephalogram to make a definite diagnosis.
From inclusion to delivery
Rate of early childhood developmental delay of the offspring
Early childhood developmental delay of the offspring refers to a significant lag or delay in achieving age-appropriate developmental milestones across one or more domains, including cognitive, language, motor, social-emotional, and adaptive skills, during the early years of life (typically from birth to 5 years of age) in comparison to established norms or peers. The assessment of early childhood developmental delay is conducted using standardized scales such as Ages Stages Questionnaires (Third Edition), Gesell Developmental Schedules, and Bayley Scales of Infant and Toddler Development. The actual measurement process will be depending on the routine pediatric settings and resources available at each participating institution.
Within 1 year after delivery
Children's height
Each child is measured twice. If the difference is less than 0.1 cm, the average of the two measurements is taken. If the difference is greater than 0.1 cm, the measurement is repeated.
Within 1 year after delivery
Children's weight
Each newborn is measured twice. If the difference is less than 0.01 kg, the average of the two measurements is taken. If the difference is greater than 0.01 kg, the measurement is repeated.
Within 1 year after delivery
Secondary Outcomes (9)
Rate of sleep disorders
From inclusion to delivery
Rate of mental and phycological disorders
From inclusion to delivery
Rate of single intrauterine fetal demise
From inclusion to delivery
Rate of gestational hypertension
From inclusion to delivery
Rate of gestational diabetes mellitus
From inclusion to delivery
- +4 more secondary outcomes
Eligibility Criteria
The ChiTwiMC is a prospective cohort that will enroll 2000 pregnant women aged 18-45 years and over from 9 large obstetrical centers of University-Affiliated Hospitals (Peking University Third Hospital; First Affiliated Hospital, Sun Yat-Sen University; Chongqing Medical University; Shengjing Hospital; Shanghai First Maternity and Infant Hospital; The First Affiliated Hospital of Anhui Medical University; International Peace Maternity and Child Health Hospital; The Second Hospital of Shandong University; Shandong Provincial Hospital). These hospitals located at 7 supercities (Beijing, Shanghai, Guangzhou, Shenyang, Jinan, Chongqing, and Hefei) of China. Pregnant women who are planning to receive prenatal healthcare and delivery in those hospitals are potential candidates for the study.
You may qualify if:
- Twin pregnancies
- Female aged between 18-45 years
- Gestational age is less than 14 weeks
- Planning to receive prenatal healthcare and delivery service at the study hospital
- Signing informed concent and willing to participate
You may not qualify if:
- Women with mental disorders or serious maternal illness that is not eligible to participate
- Inability to provide informed consent
- Pregnant women not registered in our hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- First Affiliated Hospital, Sun Yat-Sen Universitycollaborator
- Chongqing Medical Universitycollaborator
- Shengjing Hospitalcollaborator
- Peking Universitycollaborator
- Nankai Universitycollaborator
- Shanghai First Maternity and Infant Hospitalcollaborator
- The First Affiliated Hospital of Anhui Medical Universitycollaborator
- International Peace Maternity and Child Health Hospitalcollaborator
- The Second Hospital of Shandong Universitycollaborator
- Shandong Provincial Hospitalcollaborator
Study Sites (11)
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230001, China
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Peking University
Beijing, Beijing Municipality, 10091, China
Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510000, China
Shengjing Hospital
Shenyang, Liaoning, 110000, China
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
The Second Hospital of Shandong University
Jinan, Shandong, 250033, China
International Peace Maternity and Child Health Hospital
Shanghai, Shanghai Municipality, 200030, China
Shanghai First Maternity and Infant Hospital
Shanghai, Shanghai Municipality, 201204, China
Nankai University
Tianjin, Tianjin Municipality, 300071, China
Biospecimen
Collecting peripheral venous blood from husband, hair during the first trimester, peripheral venous blood and cervicovaginal secretions during the first trimester, second trimester, late pregnancy before labor, placental tissue, amionic fluid and umbilical cord blood during delivery, hair, meconium of newborns, and buccal mucosa from infants.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yuan Wei, PhD, MD
Obstetrics and Gynecology Department of Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2024
First Posted
May 16, 2024
Study Start
March 1, 2024
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
May 16, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
We have decided that the program will be confidential and not open to other researchers